High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantationLila Gilis, Florence Ader, Stéphane Morisset et al.|Bone Marrow Transplantation|2014Cited by 148
Study of ochratoxin A as an environmental risk that causes renal injury in breast-fed Egyptian infantsAhmed M. Hassan, Mohamed Sobh, Hussein Sheashaa et al.|Pediatric Nephrology|2005Cited by 67
Outcome of High-Risk and Refractory AML/MDS Patients Receiving a Flamsa Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)Marie Y. Detrait, Mauricette Michallet, Patrice Chevallier et al.|Transplantation and Cellular Therapy|2012Cited by 4
Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better ManagementMauricette Michallet, Franck E. Nicolini, Mohamed Sobh et al.|Transplantation and Cellular Therapy|2012Cited by 0
Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants from 10/10 HLA Unrelated Donors and SiblingsMarie‐Cécile Michallet, F-E Nicolini, Mohamed Sobh et al.|Transplantation and Cellular Therapy|2012Cited by 0